Adagene Inc.

US$2.00As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ADAGHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (35.61%)
Div yield —
ROE (28.50%)
Biotechnology
Beta (5Y) 0.66
PE TTM —
TSR TTM 12.36%
Mkt cap US$134.3M
ROIC (17.80%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.03
1.69%
161.55%
Hold 1|5|12|10|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.05
0.05
0.05
8.73%
21.17%
23.11%
23.59%
Revenue$M
14.69
15.32
15.25
15.52
4.16%
3.02%
5.35%
8.66%
Peers (US$134.3M)
Cap (US$)
PE
168.3M
—
140.4M
6.941x
134.3M
—
Capital
TTM
5Y
10Y
Leveragex
1.277
(0.582)
(0.605)
EBIT/Intx
0.563
1.421
1.153
Own earn%
94.34
(202.71)
(193.81)
Sh yield%
26.39
37.93
37.97
Owners
Insiders/Inst%
11.75
67.42
Short interest%
3.27
SBC / revenue%
3.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
6–11
$1 testx
0.0
Incr. ROIC%
7